000 | 01857 a2200457 4500 | ||
---|---|---|---|
005 | 20250515231743.0 | ||
264 | 0 | _c20100910 | |
008 | 201009s 0 0 eng d | ||
022 | _a1557-9859 | ||
024 | 7 |
_a10.1016/j.mcna.2010.03.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKano, Yoko | |
245 | 0 | 0 |
_aVisceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. _h[electronic resource] |
260 |
_bThe Medical clinics of North America _cJul 2010 |
||
300 |
_a743-59, xi p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAutoimmune Diseases _xchemically induced |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdiagnosis |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xchemically induced |
650 | 0 | 4 |
_aDigestive System Diseases _xchemically induced |
650 | 0 | 4 |
_aDrug Hypersensitivity _xcomplications |
650 | 0 | 4 |
_aHeart Diseases _xchemically induced |
650 | 0 | 4 |
_aHerpesviridae _xphysiology |
650 | 0 | 4 |
_aHerpesviridae Infections _xchemically induced |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 |
_aLung Diseases _xchemically induced |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xchemically induced |
650 | 0 | 4 |
_aMeningoencephalitis _xchemically induced |
650 | 0 | 4 |
_aMultiple Organ Failure _xchemically induced |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aScleroderma, Systemic _xchemically induced |
650 | 0 | 4 | _aSyndrome |
650 | 0 | 4 |
_aThyroiditis _xchemically induced |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aVirus Activation |
700 | 1 | _aIshida, Tadashi | |
700 | 1 | _aHirahara, Kazuhisa | |
700 | 1 | _aShiohara, Tetsuo | |
773 | 0 |
_tThe Medical clinics of North America _gvol. 94 _gno. 4 _gp. 743-59, xi |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.mcna.2010.03.004 _zAvailable from publisher's website |
999 |
_c19956082 _d19956082 |